Post Tagged with: "Biomarkers"

Editor’s Pick: Simple, Low-Cost, and Timely Optical Biosensors for the Detection of Epigenetic Biomarkers: The Future of Cancer Diagnosis

Editor’s Pick: Simple, Low-Cost, and Timely Optical Biosensors for the Detection of Epigenetic Biomarkers: The Future of Cancer Diagnosis

Oncology October 24, 2017 at 8:29 AM 0 comments

This issue’s Editor’s Pick is a relevant discussion paper from Lechuga et al. on the potential of simple, low-cost, and timely optical biosensors for the detection of epigenetic biomarkers in cancer diagnosis. The development of new methods for the detection and monitoring of cancer has been the subject of intenseRead More

Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria

Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria

Oncology October 24, 2017 at 8:27 AM 0 comments

Alessandro Morlacco,1 Matteo Soligo,1 Michele Colicchia,2 Avinash Nehra,2 *R. Jeffrey Karnes3 1. Padua University Hospital, Padua, Italy 2. Mayo Clinic, Rochester, Minnesota, USA 3. Urology Department, Mayo Clinic, Rochester, Minnesota, USA *Correspondence to Karnes.R@mayo.edu Disclosure: R. Jeffrey Karnes has received research funding from GenomeDx and is employed by the MayoRead More

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

Oncology October 24, 2017 at 8:23 AM 0 comments

Aline N. Zouk, *Hitesh Batra Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA *Correspondence to hbatra@uabmc.edu Disclosure: The authors have declared no conflicts of interest. Received: 19.06.17 Accepted: 18.09.17 Citation: EMJ Oncol. 2017;5[1]:103-111. Abstract Pleural malignancies constitute either primary pleural malignancies, such asRead More

Negative Biopsies with Rising Prostate-Specific Antigen. What to Do?

Negative Biopsies with Rising Prostate-Specific Antigen. What to Do?

Urology May 9, 2017 at 8:26 AM 0 comments

*Juan Gómez Rivas,1 Mario Alvarez-Maestro,1 Marcin Czarniecki,2 Stefan Czarniecki,3 Moises Rodriguez Socarras,4 Stacy Loeb5 1. Department of Urology, La Paz University Hospital, Madrid, Spain 2. Department of Radiology, Masovian Brodno Hospital, Warsaw, Poland 3. St. John Paul II Western Hospital, Grodzisk Mazowiecki, Poland 4. Department of Urology, Alvaro Cunqueiro UniversityRead More

Personalised Medicine with Companion Diagnostics: The Intercept of Medicines and Medical Devices in the Regulatory Landscape

Personalised Medicine with Companion Diagnostics: The Intercept of Medicines and Medical Devices in the Regulatory Landscape

Innovations January 10, 2017 at 8:26 AM 0 comments

*Amanda Craig Translational Neuroscience Facility and Department of Physiology, School of Medical Sciences, University of New South Wales, New South Wales, Australia *Correspondence to a.craig@unsw.edu.au Disclosure: Dr Amanda Craig is employed by the Therapeutic Goods Administration. The views and opinions expressed in this publication are those of the author and shouldRead More

In Search of Biomarkers in Eosinophilic Oesophagitis: We Are Not There Yet!

In Search of Biomarkers in Eosinophilic Oesophagitis: We Are Not There Yet!

Allergy & Immunology August 2, 2016 at 8:25 AM 0 comments

Neeti Bhardwaj,1 *Gisoo Ghaffari2 1. Department of Pediatrics, Division of Allergy and Immunology, Pennsylvania College of Medicine, Hershey, Pennsylvania, USA 2. Department of Medicine, Division of Pulmonary, Allergy, Critical Care Medicine, Pennsylvania College of Medicine, Hershey, Pennsylvania, USA *Correspondence to gghaffari@hmc.psu.edu. Disclosure: The authors have declared no conflicts of interest.Read More

Multiple Sclerosis: Where do we go from here?

Multiple Sclerosis: Where do we go from here?

Neurology July 12, 2016 at 8:25 AM 0 comments

*Marta Tejera-Alhambra,1 Lidia Fernández-Paredes,2 Clara de Andrés,3 Silvia Sánchez-Ramón2 1. Medical Department, Inmunotek, S.L., Madrid, Spain 2. Department of Clinical Immunology, Hospital Clínico San Carlos, Madrid, Spain 3. Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain *Correspondence to tejeramarta@hotmail.com Disclosure: The authors have declared no conflicts of interest.Read More

Utility of Exosomes in the Diagnosis and Treatment of Pancreatic Adenocarcinoma

Utility of Exosomes in the Diagnosis and Treatment of Pancreatic Adenocarcinoma

European Medical Journal, Oncology January 26, 2016 at 9:02 AM 0 comments

Leo I. Amodu, Asaph Levy, Crystal Kyaw, Darshan Padmanabhan, Alexandra Osman, Mukesh Tiwari, Jeffrey Nicastro, Gene Coppa, Ernesto Molmenti, *Horacio L. Rodriguez Rilo Center for Diseases of the Pancreas, Department of General Surgery, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York, USA *Correspondence to Hrilo@nshs.edu Disclosure: TheRead More

Update on Alzheimer’s Disease

Update on Alzheimer’s Disease

Neurology August 6, 2015 at 9:00 AM 0 comments

*Kurt A. Jellinger Institute of Clinical Neurobiology, Vienna, Austria *Correspondence to kurt.jellinger@univie.ac.at Disclosure: The author has declared no conflicts of interest. Received: 17.12.14 Accepted: 13.02.15 Citation: EMJ Neurol. 2015;3[1]:82-90. Abstract With the disproportionate growth of the elderly population, Alzheimer’s disease (AD), as the most common cause of dementia, has becomeRead More

Management of Refractory Lupus Nephritis

Management of Refractory Lupus Nephritis

Nephrology July 14, 2015 at 9:40 AM 0 comments

Antonis Fanouriakis,1,2 *George Bertsias1,2 1. Department of Rheumatology, Clinical Immunology, and Allergy, University Hospital of Heraklion, Heraklion, Crete, Greece 2. Institute of Molecular Biology and Biotechnology, Foundation for Research & Technology – Hellas (FORTH), Heraklion, Crete, Greece *Correspondence to gbert@med.uoc.gr Disclosure: The authors have declared no conflicts of interest. Received:Read More